CBL and myeloid neoplasm: The co-occurrence of U2AF1 and signaling gene mutations also differed across myeloid neoplasms, with NRAS and FLT3 mutations being more common with S34 mutations and CBL, PTPN11 and CSF3R mutations more common with R156/Q157 mutations.